Your browser doesn't support javascript.
loading
Mapping Peptide-Protein Interactions by Amine-Reactive Cleavable Photoaffinity Reagents.
Korovesis, Dimitris; Gaspar, Vanessa P; Beard, Hester A; Chen, Suyuan; Zahédi, René P; Verhelst, Steven H L.
Afiliación
  • Korovesis D; Laboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven-University of Leuven, Herestraat 49 Box 802, Leuven 3000, Belgium.
  • Gaspar VP; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec H3T 1E2, Canada.
  • Beard HA; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec H4A 3T2, Canada.
  • Chen S; Laboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven-University of Leuven, Herestraat 49 Box 802, Leuven 3000, Belgium.
  • Zahédi RP; AG Chemical Proteomics, Leibniz Institute for Analytical Sciences ISAS, e.V., Otto-Hahn-Str. 6b, Dortmund 44227, Germany.
  • Verhelst SHL; Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research and McGill University, Montreal, Quebec H3T 1E2, Canada.
ACS Omega ; 8(28): 25487-25495, 2023 Jul 18.
Article en En | MEDLINE | ID: mdl-37483247
Photoaffinity labeling followed by tandem mass spectrometry is an often used strategy to identify protein targets of small-molecule drugs or drug candidates, which, under ideal conditions, enables the identification of the actual drug binding site. In the case of bioactive peptides, however, identifying the distinct binding site is hampered because of complex fragmentation patterns during tandem mass spectrometry. We here report the development and use of small cleavable photoaffinity reagents that allow functionalization of bioactive peptides for light-induced covalent binding to their protein targets. Upon cleavage of the covalently linked peptide drug, a chemical remnant of a defined mass remains on the bound amino acid, which is then used to unambiguously identify the drug binding site. Applying our approach to known peptide-drug/protein pairs with reported crystal structures, such as the calmodulin-melittin interaction, we were able to validate the identified binding sites based on structural models. Overall, our cleavable photoaffinity labeling strategy represents a powerful tool to enable the identification of protein targets and specific binding sites of a wide variety of bioactive peptides in the future.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Omega Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Omega Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos